跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 753 条关于
“Syk”
全部
753
临床试验
238
药物
392
机构
18
资讯
105
去年
Hutchison MediPharma's Sovleplenib Demonstrates Efficacy in Autoimmune Disorders
去年
Sanofi Licenses Dual JAK/SYK Inhibitor Gusacitinib from Formation Bio in €545 Million Deal
4个月前
HUTCHMED's Sovleplenib Receives Priority Review and Breakthrough Designation in China for Rare Blood Disorder
8个月前
HUTCHMED's Sovleplenib Meets Primary Endpoint in Phase III Trial for Warm Autoimmune Hemolytic Anemia
去年
Rigel's Fostamatinib Enrolls First Patient in Phase I Sickle Cell Disease Trial
11个月前
Ignota Labs Acquires Kronos Bio's Failed Clinical Pipeline to Revive Shelved Cancer and Autoimmune Drugs
去年
NIH Launches Study of Fostamatinib for Sickle Cell Disease Treatment
去年
TAVALISSE® (Fostamatinib) Approved in Mexico for Chronic ITP Treatment
去年
Breakthrough Treatments Transform Landscape for Rare Hemolytic Anemias: From C5 Inhibitors to Novel Therapeutic Approaches
去年
Stryker Unveils Artix Thrombectomy System: A Breakthrough in Arterial Blood Clot Treatment
第 1 页,共 11 页
上一页
下一页